53 related articles for article (PubMed ID: 22768826)
1. [Estimation of health-care costs for cervical uterine neoplasm].
Sánchez-Román FR; de Jesús Carlos-Rivera F; Guzmán-Caniupan JA; Escudero-de Los Ríos P; Juárez-Pérez CA; Aguilar-Madrid G
Rev Med Inst Mex Seguro Soc; 2012; 50(1):99-106. PubMed ID: 22768826
[TBL] [Abstract][Full Text] [Related]
2. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
3. [Estimated cost of managing invasive cervical cancer in Tunisia].
Ben Gobrane H; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
Sante Publique; 2009; 21(6):561-9. PubMed ID: 20429226
[TBL] [Abstract][Full Text] [Related]
4. Direct costs of cervical cancer management in Morocco.
Berraho M; Najdi A; Mathoulin-Pelissier S; Salamon R; Nejjari C
Asian Pac J Cancer Prev; 2012; 13(7):3159-63. PubMed ID: 22994727
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of concurrent chemoradiation in comparison with radiation alone in locally advanced cervical cancer.
Manusirivithaya S; Sripramote M; Tangjitgamol S; Sanjareonsuttikul N; Pisarnturakit P
J Med Assoc Thai; 2005 Aug; 88(8):1035-44. PubMed ID: 16404829
[TBL] [Abstract][Full Text] [Related]
6. ["Cost-effectiveness" of cervical screening].
Kostova P
Akush Ginekol (Sofiia); 2007; 46(6):32-4. PubMed ID: 17974169
[TBL] [Abstract][Full Text] [Related]
7. [Treatment costs of malignant cervical cancer in Poland in 2011-2012--the case of Silesian Voivodeship].
Holecki T; Sobczyk K; Nawrocki S; Woźniak-Holecka J; Skrzypek M; Bocionek A
Ginekol Pol; 2015 Nov; 86(11):849-55. PubMed ID: 26817317
[TBL] [Abstract][Full Text] [Related]
8. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan.
Insinga RP; Ye X; Singhal PK; Carides GW
Gynecol Oncol; 2008 Nov; 111(2):188-96. PubMed ID: 18757080
[TBL] [Abstract][Full Text] [Related]
9. Hospital costs incurred by the Italian National Health Service for invasive cervical cancer.
Ferrandina G; Marcellusi A; Mennini FS; Petrillo M; Di Falco C; Scambia G
Gynecol Oncol; 2010 Nov; 119(2):243-9. PubMed ID: 20650507
[TBL] [Abstract][Full Text] [Related]
10. Medical costs for the treatment of cervical cancer at central hospitals in Vietnam.
Nguyen AD; Hoang MV; Nguyen CC
Health Care Women Int; 2018 Apr; 39(4):442-449. PubMed ID: 29125392
[TBL] [Abstract][Full Text] [Related]
11. Incidence of invasive cervical cancer and direct costs associated with its management in Italy.
Ricciardi A; Largeron N; Giorgi Rossi P; Raffaele M; Cohet C; Federici A; Palazzo F
Tumori; 2009; 95(2):146-52. PubMed ID: 19579858
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of primary HPV screening for cervical cancer in Germany--a decision analysis.
Sroczynski G; Schnell-Inderst P; Mühlberger N; Lang K; Aidelsburger P; Wasem J; Mittendorf T; Engel J; Hillemanns P; Petry KU; Krämer A; Siebert U
Eur J Cancer; 2011 Jul; 47(11):1633-46. PubMed ID: 21482103
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the cost of cervical cancer at the National Institute of Oncology, Rabat.
Cheikh A; El Majjaoui S; Ismaili N; Cheikh Z; Bouajaj J; Nejjari C; El Hassani A; Cherrah Y; Benjaafar N
Pan Afr Med J; 2016; 23():209. PubMed ID: 27347298
[TBL] [Abstract][Full Text] [Related]
14. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
Martin-Hirsch P; Rash B; Martin A; Standaert B
BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
[TBL] [Abstract][Full Text] [Related]
15. Determinants of hospital length of stay for cervical dysplasia and cervical cancer: does managed care matter?
Berg GD; Chattopadhyay SK
Am J Manag Care; 2004 Jan; 10(1):33-8. PubMed ID: 14738185
[TBL] [Abstract][Full Text] [Related]
16. Collecting direct non-health care and time cost data: application to screening and diagnosis of cervical cancer.
Cantor SB; Levy LB; Cárdenas-Turanzas M; Basen-Engquist K; Le T; Beck JR; Follen M
Med Decis Making; 2006; 26(3):265-72. PubMed ID: 16751325
[TBL] [Abstract][Full Text] [Related]
17. Determining costs of health care services for cost-effectiveness analyses: the case of cervical cancer prevention and treatment.
Helms LJ; Melnikow J
Med Care; 1999 Jul; 37(7):652-61. PubMed ID: 10424636
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
Bidus MA; Maxwell GL; Kulasingam S; Rose GS; Elkas JC; Chernofsky M; Myers ER
Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402
[TBL] [Abstract][Full Text] [Related]
19. Overall care cost comparison between robotic and laparoscopic surgery for endometrial and cervical cancer.
Desille-Gbaguidi H; Hebert T; Paternotte-Villemagne J; Gaborit C; Rush E; Body G
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):348-52. PubMed ID: 24135382
[TBL] [Abstract][Full Text] [Related]
20. What is the least costly strategy to evaluate cervical abnormalities in rural women? Comparing telemedicine, local practitioners, and expert physicians.
Bishai DM; Ferris DG; Litaker MS
Med Decis Making; 2003; 23(6):463-70. PubMed ID: 14672106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
